Aminophylline News and Research

RSS

Soaring healthcare costs for RSV-related complications in US seniors 60 plus

In a recent study published in the journal Open Forum Infectious Diseases, researchers explored the correlation between complications caused by a respiratory syncytial virus (RSV) and the associated healthcare costs.

18 Apr 2023

New insight into Duchenne muscular dystrophy

Armed with a zebrafish model of Duchenne muscular dystrophy and a library of 1,200 chemicals already approved for human use, researchers at Children's Hospital Boston have identified a compound that reverses the loss of muscle structure and function associated with DMD, seemingly by compensating for the loss of a critical protein.

19 Mar 2011

Astellas Pharma announces Phase IV study results of Lexiscan injection at ASNC session

Today Astellas Pharma US, Inc. announced results of a Phase IV study showing Lexiscan(regadenoson) Injection was comparable to placebo in causing a >15% decrease in forced expiratory volume in one second (FEV1) in subjects with asthma or chronic obstructive pulmonary disease (COPD) who are likely candidates for myocardial perfusion imaging (MPI) studies.

27 Sep 2010

We know they need caffeine, but how it works on the newborn is the subject of a new study

Every morning, millions of adults consume voluminous cups of coffee, seeking the jolting effect of caffeine. As these adults consume their coffee, they do so unaware that some of the youngest Americans are also getting a treatment of caffeine - not to stay awake, but to assist in treating a major sleep disorder found in some neonates.

21 Jul 2004